tiprankstipranks
Avanos Medical (AVNS)
NYSE:AVNS
US Market
AVNS
Avanos Medical
RESEARCH TOOLSreports
Want to see AVNS full AI Analyst Report?

Avanos Medical (AVNS) Ratios

177 Followers

Avanos Medical Ratios

AVNS's free cash flow for Q4 2025 was $0.48. For the 2025 fiscal year, AVNS's free cash flow was decreased by $ and operating cash flow was $0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.15 2.15 2.37 2.08 3.27
Quick Ratio
 1.26 1.26 1.53 1.38 2.57
Cash Ratio
 0.54 0.54 0.65 0.37 0.67
Solvency Ratio
 -0.10 -0.13 -1.06 -0.04 0.18
Operating Cash Flow Ratio
 0.45 0.45 0.61 0.14 0.48
Short-Term Operating Cash Flow Coverage
 7.32 7.32 10.71 3.77 14.66
Net Current Asset Value
$ 59.90M$ 59.90M$ 67.70M$ 30.90M$ 128.40M
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.12 0.15 0.12 0.16
Debt-to-Equity Ratio
 0.17 0.17 0.21 0.17 0.21
Debt-to-Capital Ratio
 0.14 0.14 0.17 0.14 0.18
Long-Term Debt-to-Capital Ratio
 0.10 0.10 0.13 0.11 0.15
Financial Leverage Ratio
 1.38 1.38 1.39 1.37 1.38
Debt Service Coverage Ratio
 -1.18 -2.46 -15.21 2.06 4.48
Interest Coverage Ratio
 -7.90 -15.40 3.28 4.33 4.19
Debt to Market Cap
 0.09 0.19 0.18 0.16 0.18
Interest Debt Per Share
 2.95 2.87 3.97 4.81 6.12
Net Debt to EBITDA
 -2.02 -1.18 -0.18 2.40 1.92
Profitability Margins
Gross Profit Margin
49.77%49.77%55.44%56.39%57.62%
EBIT Margin
-8.33%-8.87%-56.86%1.05%5.36%
EBITDA Margin
-2.78%-4.73%-50.25%7.52%11.37%
Operating Profit Margin
-8.78%-8.78%5.82%9.65%6.12%
Pretax Profit Margin
-9.44%-9.44%-58.64%-1.17%3.90%
Net Profit Margin
-9.68%-9.68%-57.01%-9.18%7.38%
Continuous Operations Profit Margin
-9.68%-9.68%-56.16%-1.47%3.14%
Net Income Per EBT
102.57%102.57%97.22%782.28%189.14%
EBT Per EBIT
107.47%107.47%-1008.25%-12.15%63.72%
Return on Assets (ROA)
-6.32%-6.32%-33.97%-3.65%2.83%
Return on Equity (ROE)
-8.56%-8.73%-47.33%-5.00%3.91%
Return on Capital Employed (ROCE)
-6.78%-6.78%4.05%4.46%2.63%
Return on Invested Capital (ROIC)
-6.65%-6.65%3.80%4.39%2.09%
Return on Tangible Assets
-12.10%-12.10%-66.88%-9.41%6.37%
Earnings Yield
-5.94%-13.03%-53.54%-5.91%3.98%
Efficiency Ratios
Receivables Turnover
 6.76 6.76 5.18 4.71 4.07
Payables Turnover
 6.35 6.35 5.64 5.21 4.27
Inventory Turnover
 2.38 2.38 2.21 1.80 2.19
Fixed Asset Turnover
 4.97 4.97 4.75 4.68 4.68
Asset Turnover
 0.65 0.65 0.60 0.40 0.38
Working Capital Turnover Ratio
 3.56 3.36 2.87 1.96 1.90
Cash Conversion Cycle
 149.89 149.89 171.10 210.31 170.67
Days of Sales Outstanding
 54.03 54.03 70.47 77.41 89.58
Days of Inventory Outstanding
 153.38 153.38 165.29 202.89 166.57
Days of Payables Outstanding
 57.52 57.52 64.66 69.99 85.49
Operating Cycle
 207.41 207.41 235.77 280.30 256.16
Cash Flow Ratios
Operating Cash Flow Per Share
 1.61 1.61 2.19 0.70 1.94
Free Cash Flow Per Share
 0.93 0.93 1.80 0.31 1.53
CapEx Per Share
 0.68 0.68 0.39 0.38 0.41
Free Cash Flow to Operating Cash Flow
 0.58 0.58 0.82 0.45 0.79
Dividend Paid and CapEx Coverage Ratio
 2.36 2.36 5.66 1.82 4.71
Capital Expenditure Coverage Ratio
 2.36 2.36 5.66 1.82 4.71
Operating Cash Flow Coverage Ratio
 0.58 0.58 0.59 0.15 0.33
Operating Cash Flow to Sales Ratio
 0.11 0.11 0.15 0.05 0.13
Free Cash Flow Yield
3.75%8.27%11.32%1.40%5.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -16.87 -7.67 -1.87 -16.91 25.13
Price-to-Sales (P/S) Ratio
 1.64 0.74 1.06 1.55 1.86
Price-to-Book (P/B) Ratio
 1.47 0.67 0.88 0.85 0.98
Price-to-Free Cash Flow (P/FCF) Ratio
 26.74 12.09 8.83 71.59 17.73
Price-to-Operating Cash Flow Ratio
 15.34 6.98 7.27 32.26 13.96
Price-to-Earnings Growth (PEG) Ratio
 -0.35 0.09 >-0.01 0.08 0.03
Price-to-Fair Value
 1.47 0.67 0.88 0.85 0.98
Enterprise Value Multiple
 -61.11 -16.88 -2.30 23.06 18.23
Enterprise Value
 1.19B 560.37M 794.82M 1.17B 1.42B
EV to EBITDA
 -60.99 -16.88 -2.30 23.06 18.23
EV to Sales
 1.70 0.80 1.16 1.73 2.07
EV to Free Cash Flow
 27.60 13.00 9.59 79.91 19.81
EV to Operating Cash Flow
 15.92 7.50 7.89 36.01 15.60
Tangible Book Value Per Share
 5.72 5.72 5.67 4.31 6.33
Shareholders’ Equity Per Share
 16.77 16.77 18.01 26.53 27.53
Tax and Other Ratios
Effective Tax Rate
 -0.03 -0.03 0.04 -0.25 0.19
Revenue Per Share
 15.11 15.11 14.95 14.45 14.59
Net Income Per Share
 -1.46 -1.46 -8.52 -1.33 1.08
Tax Burden
 1.03 1.03 0.97 7.82 1.89
Interest Burden
 1.13 1.06 1.03 -1.11 0.73
Research & Development to Revenue
 0.03 0.03 0.04 0.04 0.04
SG&A to Revenue
 0.42 0.31 0.46 0.00 0.00
Stock-Based Compensation to Revenue
 0.02 0.00 0.02 0.02 0.02
Income Quality
 -1.02 -1.02 -0.26 -0.52 1.80
Currency in USD